Publications by authors named "O Saavedra"

Purpose: Innate immune cell-based therapies have shown promising antitumor activity against solid and hematologic malignancies. AFM24, a bispecific innate cell engager, binds CD16A on natural killer (NK) cells/macrophages and EGFR on tumor cells, redirecting antitumor activity towards tumors. The safety and tolerability of AFM24 was evaluated in this Phase 1/2a dose escalation/dose expansion study in patients with recurrent or persistent, advanced solid tumors known to express EGFR.

View Article and Find Full Text PDF

Cancer immunotherapies with antibodies blocking immune checkpoint molecules are clinically active across multiple cancer entities and have markedly improved cancer treatment. Yet, response rates are still limited, and tumour progression commonly occurs. Soluble and cell-bound factors in the tumour microenvironment negatively affect cancer immunity.

View Article and Find Full Text PDF

Purpose: Immune gene expression signatures are emerging as potential biomarkers for immunotherapy (IO). VIGex is a 12-gene expression classifier developed in both nCounter (Nanostring) and RNA sequencing (RNA-seq) assays and analytically validated across laboratories. VIGex classifies tumor samples into hot, intermediate-cold (I-Cold), and cold subgroups.

View Article and Find Full Text PDF

There has been substantial progress in orthognathic surgery over the last 20 years, propelled by developments in 3D technology. These have led to enhanced predictability and precision, and simplified surgical planning. This transformative shift has introduced patient-specific implants (PSI) and cutting guides as viable alternatives to conventional techniques, elevating the overall effectiveness of surgical procedures.

View Article and Find Full Text PDF
Article Synopsis
  • Pamiparib, a selective inhibitor targeting certain cancer vulnerabilities, was tested in a study with temozolomide (TMZ) for treating advanced solid tumors in adults.
  • The study involved administering pamiparib alongside escalating doses of TMZ to find safe and effective dosing, while also monitoring for side effects and tumor response.
  • Results showed that while the combination had some modest effectiveness, the main side effects were anemia, nausea, and fatigue, with no reported treatment-related deaths.
View Article and Find Full Text PDF